Skraban–Deardorff Syndrome

Skraban–Deardorff syndrome (also known as WDR26-related disorder or Intellectual Disability with Seizures, Abnormal Gait, and Distinctive Facial Features) is a rare, autosomal-dominant neurodevelopmental syndrome. It is caused by de novo pathogenic variants in the WDR26 gene, first described in 2017 in a cohort of 15 individuals. Affected patients exhibit global developmental delay, variable intellectual disability, early-onset seizures, hypotonia, feeding difficulties, an ataxic gait, and characteristic coarse facial features (prominent maxilla, broad nasal tip, widely spaced teeth, and upper-lip elevation revealing upper gingiva) ncbi.nlm.nih.govmalacards.org.

Management is entirely supportive and symptom-driven. There is no disease-modifying therapy; instead, interventions target each clinical manifestation—developmental delay, seizures, skeletal anomalies, sleep disorders, etc.—using standard approaches from pediatric neurology, genetics, and rehabilitation medicine ncbi.nlm.nih.goven.wikipedia.org.

Skraban–Deardorff syndrome, also called WDR26‑related intellectual disability, is a rare genetic disorder first described in 2017. It arises when a person has a harmful change in one copy of the WDR26 gene, located on chromosome 1q42.11–q42.12. Because the WDR26 protein plays an essential role in controlling how other proteins are broken down and how genes are turned on or off during brain development, insufficient amounts of functional WDR26 lead to widespread effects on the nervous system. Individuals with this syndrome typically show global developmental delays, varying degrees of intellectual disability, distinct facial features, and often seizures and movement differences. Case reports suggest it is very rare—fewer than 200 people have been diagnosed worldwide as of mid‑2025—and most cases occur spontaneously (de novo), meaning the mutation was not inherited from either parent.

Types of Skraban–Deardorff Syndrome

While all cases share the core problem of WDR26 insufficiency, two main clinical forms can be described:

1. Monogenic WDR26 Variant Type
This form is caused by a single‑gene pathogenic variant in WDR26. It can include point mutations—such as missense (single amino acid change), nonsense (early stop codon), frameshift (insertions or deletions that shift the reading frame), or splice‑site variants—that reduce or eliminate WDR26 protein function.

2. 1q41q42 Microdeletion Type
In this form, a larger chromosomal deletion removes the WDR26 gene along with some neighboring genes. Although it shares many features with the monogenic form, additional genes in the deleted region may add symptoms not typical of classic Skraban–Deardorff syndrome.

Causes

  1. Missense Variants in WDR26
    A single nucleotide change that substitutes one amino acid in WDR26, potentially altering protein folding or stability.
  2. Nonsense Variants in WDR26
    A point mutation that creates an early stop codon, leading to a truncated, nonfunctional protein.
  3. Frameshift Variants in WDR26
    Insertions or deletions of bases that shift the reading frame, drastically altering the downstream protein sequence.
  4. Splice‑Site Variants in WDR26
    Changes at intron–exon boundaries that disrupt normal splicing, often resulting in a faulty protein.
  5. In‑Frame Deletions in WDR26
    Removal of a small number of bases that does not shift the reading frame but deletes a critical protein region.
  6. Whole‑Gene Deletion (Copy Number Variant)
    Loss of the entire WDR26 gene, typically due to a microdeletion at 1q41q42.
  7. Exon‑Level Deletions
    Deletion of one or more exons within WDR26, leading to absence of key protein domains.
  8. Gene Fusion Events
    Rare chromosomal rearrangements that fuse WDR26 with another gene, disrupting normal function.
  9. Germline Mosaicism
    A mutation present in some parental germ cells that may pass to the child, even if parents show no symptoms.
  10. Paternal Age‑Related De Novo Mutation
    Increased risk of new WDR26 variants arising in sperm as men age.
  11. Maternal Age‑Related De Novo Mutation
    Although less common, egg cell mutations can accumulate with maternal age.
  12. Replication Slippage Errors
    DNA slippage during early embryo cell divisions causing small insertions or deletions in WDR26.
  13. Faulty DNA Repair Mechanisms
    Defects in the cell’s ability to correct DNA errors, allowing harmful WDR26 changes to persist.
  14. Ionizing Radiation Exposure
    High‑energy radiation that can damage DNA and introduce mutations in early embryonic cells.
  15. Chemical Mutagens
    Exposure to certain chemicals (e.g., industrial solvents) that increase the risk of DNA damage in developing embryos.
  16. Chromosomal Translocations
    Break and reattachment of chromosome segments that can disrupt WDR26 regulatory regions.
  17. Retrotransposon Insertions
    Mobile genetic elements inserting into WDR26, interrupting its coding sequence.
  18. Epigenetic Silencing
    Abnormal DNA methylation or chromatin changes reducing WDR26 expression without altering sequence.
  19. Uniparental Disomy with Hidden Mutation
    Two copies of chromosome 1 from one parent—if that parent carries a recessive WDR26 variant, it may become unmasked.
  20. Balanced Translocation Disrupting Regulatory Elements
    A subtle rearrangement that leaves WDR26 coding intact but disrupts sequences needed for its proper activation.

Symptoms

  1. Global Developmental Delay
    All areas of development, including motor and language skills, progress slower than expected.
  2. Intellectual Disability
    Varying levels of cognitive challenges, from mild learning difficulties to severe impairment.
  3. Seizures
    Epileptic events—such as tonic‑clonic, absence, or febrile seizures—common in early childhood.
  4. Hypotonia (Low Muscle Tone)
    Reduced muscle stiffness, leading to floppy posture and delayed motor milestones.
  5. Abnormal Gait
    Unusual walking patterns, including wide‑based steps or toe‑walking.
  6. Feeding Difficulties
    Poor sucking/swallowing in infancy, sometimes requiring feeding support.
  7. Failure to Thrive
    Slow weight gain and growth due to feeding and metabolic challenges.
  8. Distinct Facial Features
    Coarse facies with broad nasal tip, flat Cupid’s bow, widely spaced teeth, and gingival enlargement.
  9. Large‑Appearing Eyes
    Prominent eyebrows and irides giving the eyes a large look; may include strabismus or refractive errors.
  10. Speech Delay or Absence
    Slow development of language; some individuals remain nonverbal.
  11. Repetitive Behaviors
    Rocking, hand flapping, or other stereotypies resembling autism spectrum behaviors.
  12. Friendly and Outgoing Demeanor
    Many patients are described as sociable and happy despite developmental challenges.
  13. Motor Coordination Problems
    Difficulty with daily tasks like dressing or tying shoelaces.
  14. Hyperactivity or Attention Difficulties
    Challenges sustaining focus and control of impulses.
  15. Sleep Disturbances
    Problems falling asleep or staying asleep, exacerbating daytime fatigue.
  16. Sensory Processing Differences
    Over‑ or under‑sensitivity to sound, light, or touch.
  17. Microcephaly (Sometimes)
    Head circumference smaller than average, seen in a minority of cases.
  18. Short Philtrum or Pointed Chin
    Variations in facial structure adding to the distinct appearance.
  19. Cleft Palate (Rarely)
    An opening in the roof of the mouth that may complicate feeding and speech.
  20. Skeletal Anomalies (Occasional)
    Mild contractures of limbs, high‑arched feet, or hip dysplasia in a few individuals.

Diagnostic Tests

Physical Exam

  1. Growth and Head Circumference Measurement
    Regular tracking of weight, height, and head size to spot growth concerns early.
  2. General Neurological Exam
    Assessment of reflexes, muscle tone, and posture to identify hypotonia and coordination issues.
  3. Craniofacial Inspection
    Detailed look at facial features—nasal shape, lip contour, dental spacing, and gum enlargement.
  4. Gait Analysis
    Observation of walking patterns to note wide base, toe‑walking, or balance problems.
  5. Motor Milestone Evaluation
    Checking when the child rolls, sits, stands, and walks compared to typical age ranges.
  6. Ophthalmological Inspection
    Simple eye alignment and tracking tests to detect strabismus or other ocular issues.
  7. Oral Motor Assessment
    Evaluation of tongue, palate, and jaw movement to plan feeding therapies.
  8. Behavioral Observation
    Watching for repetitive motions, social interaction style, and attention span.

Manual Tests

  1. Muscle Strength Testing
    Grading muscle power in arms and legs to identify weak muscle groups.
  2. Deep Tendon Reflexes
    Using a reflex hammer to check knee, ankle, and elbow reflexes for signs of neurological dysfunction.
  3. Tone Assessment (Modified Ashworth Scale)
    Rating resistance to passive movement, helping track hypotonia severity.
  4. Balance Tests (Romberg Sign)
    Assessing ability to stand with feet together, eyes closed, to uncover coordination deficits.
  5. Fine Motor Skill Tasks
    Tasks like picking up small objects or stacking blocks to measure dexterity.
  6. Sensory Testing
    Light touch, vibration, and proprioception tests to evaluate sensory processing.
  7. Oral Reflex Testing
    Checking rooting, suck, and swallow reflexes in infants to guide feeding support.
  8. Gait and Posture Palpation
    Feeling muscle tightness or joint alignment during movement.

Lab and Pathological Tests

  1. Chromosomal Microarray Analysis
    Detects copy number changes, including 1q41q42 microdeletion.
  2. Targeted WDR26 Gene Sequencing
    Examines each coding exon to find point variants.
  3. Whole Exome Sequencing
    Comprehensive screen of all protein‑coding genes, often the first choice in undiagnosed developmental delay.
  4. Gene Panel Testing
    Sequencing a group of genes known to cause intellectual disability, including WDR26.
  5. qPCR for Exon‑Level Copy Number
    Quantifies DNA to detect small deletions or duplications in WDR26.
  6. RNA Studies
    Analysis of WDR26 messenger RNA to confirm splicing abnormalities.
  7. Methylation Studies
    Rules out imprinting disorders and checks for epigenetic silencing of WDR26.
  8. Parental Testing for Mosaicism
    Examining parent DNA to detect low‑level WDR26 variants in germ cells.

Electrodiagnostic Tests

  1. Electroencephalography (EEG)
    Records brain electrical activity to identify seizure types and patterns.
  2. Evoked Potentials
    Measures neural response to visual, auditory, or sensory stimuli, assessing neural pathway integrity.
  3. Nerve Conduction Studies
    Evaluates speed of signals in peripheral nerves, helpful if neuropathy is suspected.
  4. Electromyography (EMG)
    Assesses electrical activity of muscles at rest and during contraction.
  5. Long‑Term Video EEG Monitoring
    Continuous recording to capture intermittent seizure events.
  6. Sleep EEG
    Specifically records brain activity during sleep to detect nocturnal seizures.
  7. Evoked Motor Potentials
    Stimulates motor pathways to measure conduction from brain to muscle.
  8. Amplitude Integrated EEG (aEEG)
    Simplified EEG for continuous bedside monitoring in infants.

Imaging Tests

  1. Magnetic Resonance Imaging (MRI) of Brain
    Detailed images to spot structural anomalies like benign white matter changes.
  2. Computed Tomography (CT) Scan
    Faster imaging to rule out acute issues, though used less for developmental disorders.
  3. Cranial Ultrasound
    Bedside exam for infants with open fontanelle to look for major brain malformations.
  4. Skeletal Survey X‑Rays
    Series of X‑rays checking for bone anomalies, especially if contractures are present.
  5. High‑Resolution 3D MRI
    Advanced technique to examine subtle cortical and cerebellar differences.
  6. Functional MRI (fMRI)
    Measures brain activity during tasks, useful in research settings.
  7. Magnetic Resonance Spectroscopy (MRS)
    Assesses brain chemistry to detect metabolic disturbances.
  8. Diffusion Tensor Imaging (DTI)
    Visualizes white matter tracts, helping understand connectivity differences.

Non-Pharmacological Treatments

Physiotherapy and Electrotherapy

1. Early Intervention Physical Therapy
Early, intensive physical therapy focuses on improving gross motor function through play-based activities tailored to each child’s abilities. By engaging in guided exercises that mimic everyday tasks—sitting, reaching, standing—this therapy harnesses neuroplasticity to strengthen motor pathways and build muscle tone en.wikipedia.orgmdpi.com.

2. Neurodevelopmental Treatment (NDT/Bobath Approach)
NDT uses hands-on facilitation to normalize muscle tone, inhibit atypical reflexes, and promote functional movement patterns. Therapists guide children through posture and movement corrections, enhancing sensorimotor integration and cortical reorganization careoptionsforkids.com.

3. Task-Oriented Training
Through repetitive practice of meaningful tasks (e.g., reaching for objects, climbing steps), this approach strengthens specific neural circuits underlying those activities. Task specificity drives motor learning by reinforcing the synaptic connections involved in each action mdpi.com.

4. Gait Training
Using parallel bars, treadmills, or assistive devices, therapists facilitate walking patterns. Repetitive stepping under controlled conditions improves stride symmetry, balance, and postural control by engaging central pattern generators in the spinal cord cerebralpalsyguidance.com.

5. Balance Training
Exercises on wobble boards and foam surfaces challenge postural sway, prompting adaptations in vestibular and proprioceptive pathways. Enhanced sensory feedback stabilizes the trunk and limbs, reducing falls cerebralpalsyguidance.com.

6. Strength Training
Progressive resistance exercises (e.g., theraband, light weights) target key muscle groups to increase force-generating capacity. Improved muscle strength supports functional tasks and counters hypotonia cerebralpalsyguidance.com.

7. Proprioceptive Neuromuscular Facilitation (PNF)
Diagonal and spiral movement patterns, combined with manual resistance, stimulate proprioceptors and facilitate coordinated muscle activation. PNF enhances joint range of motion and neuromuscular control mdpi.com.

8. Hydrotherapy (Aquatic Therapy)
Water buoyancy reduces gravitational forces, allowing children to practice movements with less effort. Warm water also relaxes muscles and provides uniform resistance, improving strength, coordination, and confidence thecenter4autism.org.

9. Functional Electrical Stimulation (FES)
Low-energy electrical pulses delivered to peripheral nerves elicit muscle contractions. Studies in pediatric neurodevelopmental disorders show FES can improve gait speed, muscle mass, and motor performance by enhancing muscle activation and promoting cortical reorganization cerebralpalsyguidance.com.

10. Therapeutic Ultrasound
Ultrasound waves (0.7–3.3 MHz) produce thermal and non-thermal effects—increased blood flow, collagen extensibility, and reduced inflammation. In physical therapy, it aids pain relief and tissue healing, facilitating participation in other activities en.wikipedia.org.

11. Low-Intensity Pulsed Ultrasound (LIPUS)
Pulsed mechanical waves stimulate cellular pathways (cavitation, acoustic streaming), promoting anti-inflammatory effects and tissue regeneration. While more studied in bone healing, LIPUS shows promise in enhancing MSC therapies and may support musculoskeletal health en.wikipedia.org.

12. Sonodynamic Therapy
Combining ultrasound with sonosensitizers, this emerging technique generates reactive oxygen species to modulate cellular signaling. Early research suggests potential in muscle and nerve repair when paired with appropriate agents en.wikipedia.org.

13. Constraint-Induced Movement Therapy (CIMT)
By restraining the unaffected limb, CIMT forces use of the weaker side, driving cortical plasticity. Though best studied in stroke, adaptations for developmental disorders can improve unilateral motor skills pubmed.ncbi.nlm.nih.gov.

14. Hippotherapy
Occupational or physical therapists use horse movements to engage trunk control, balance, and coordination. Rhythmical gait patterns of the horse mimic human walking, stimulating postural reflexes and strengthening core musculature en.wikipedia.org.

15. Biofeedback Therapy
Using visual or auditory feedback (e.g., EMG-based systems), children learn to voluntarily modulate muscle activity. Enhanced self-awareness of muscle tension promotes improved motor control and relaxation pubmed.ncbi.nlm.nih.gov.

Exercise Therapies

16. Structured Play-Based Exercise
Guided play (obstacle courses, ball games) enhances endurance, coordination, and social interaction by embedding therapeutic goals into enjoyable activities storkphysio.com.

17. Yoga
Gentle poses and breathing exercises improve flexibility, balance, and body awareness. Mindful movement fosters calming effects, reducing anxiety and enhancing attention pubmed.ncbi.nlm.nih.gov.

18. Pilates
Focus on core stability, controlled movement, and breathing supports postural alignment and trunk strength—vital for functional mobility mdpi.com.

19. Therapeutic Horseback Riding Programs
Community-based adaptive riding not only builds motor skills but also social communication and cognitive flexibility in children with ID and ASD pmc.ncbi.nlm.nih.gov.

20. Trampoline Therapy
Bouncing on trampolines enhances vestibular input, balance, and lower limb strength. The dynamic surface challenges postural reflexes in a fun, motivating setting storkphysio.com.

Mind-Body Approaches

21. Mindfulness Meditation
Short, guided mindfulness sessions teach self-regulation, stress reduction, and improved focus—beneficial for children with cognitive and behavioral challenges pubmed.ncbi.nlm.nih.gov.

22. Music Therapy
Rhythmic entrainment and melodic engagement support motor planning, speech development, and emotional expression. Improvisational music also fosters social interaction molecularautism.biomedcentral.com.

23. Art Therapy
Creative activities using different media (painting, clay) promote fine motor coordination, sensory integration, and non-verbal communication, enhancing self-esteem molecularautism.biomedcentral.com.

24. Animal-Assisted Therapy
Interactions with therapy animals (dogs, rabbits) reduce anxiety and support emotional regulation, attention, and social skills via the oxytocin pathway pubmed.ncbi.nlm.nih.gov.

25. Dance/Movement Therapy
Structured dance sequences facilitate body awareness, coordination, and expressive communication. Movement to music engages both motor and cognitive circuits molecularautism.biomedcentral.com.

Educational Self-Management

26. Parent Training Programs
Teaching caregivers behavior management, scaffolding strategies, and home-based exercises empowers consistent skill practice and generalization pmc.ncbi.nlm.nih.gov.

27. Social Skills Training
Small-group sessions using role-play and modeling improve peer interaction, emotion recognition, and pragmatic communication pmc.ncbi.nlm.nih.gov.

28. Cognitive-Behavioral Therapy (CBT)
Adapted CBT helps manage anxiety, frustration, and self-regulation through structured thinking and coping skills practice who.int.

29. Self-Monitoring Strategies
Visual schedules, checklists, and token systems encourage autonomy in daily tasks and reinforce positive behaviors pmc.ncbi.nlm.nih.gov.

30. Individualized Education Program (IEP) Planning
Collaborative goal-setting with schools ensures tailored academic accommodations and therapy integration for maximal learning en.wikipedia.org.

Pharmacological Treatments

All medications are prescribed based on the individual’s specific symptoms. Below are 20 key drugs with dosage, class, timing, and major side effects.

1. Levetiracetam (Keppra)
• Class: Broad-spectrum anticonvulsant
• Dosage: Start 10 mg/kg twice daily, titrate by 10 mg/kg every 2 weeks up to 60 mg/kg/day (max 3 000 mg/day)
• Timing: Morning and bedtime
• Side Effects: Somnolence, irritability, dizziness, headache, behavioral changes mayoclinic.orgncbi.nlm.nih.gov.

2. Valproic Acid (Depakote)
• Class: Broad-spectrum anticonvulsant
• Dosage: 15 mg/kg/day in divided doses, increase by 5–10 mg/kg weekly (target 30–60 mg/kg/day)
• Timing: With meals BID or TID
• Side Effects: Hepatotoxicity, thrombocytopenia, weight gain, tremor, teratogenicity verywellhealth.com.

3. Lamotrigine (Lamictal)
• Class: Broad-spectrum anticonvulsant
• Dosage: Start 0.15 mg/kg once daily, titrate slowly over 6 weeks to 1–5 mg/kg/day
• Timing: Once daily
• Side Effects: Rash (including Stevens–Johnson), dizziness, nausea verywellhealth.com.

4. Carbamazepine (Tegretol)
• Class: Sodium-channel blocker
• Dosage: 5 mg/kg twice daily, increase by 5 mg/kg weekly (target 10–20 mg/kg/day)
• Timing: BID
• Side Effects: Hyponatremia, drowsiness, rash, hepatic enzyme induction verywellhealth.com.

5. Topiramate (Topamax)
• Class: Broad-spectrum anticonvulsant
• Dosage: Start 1 mg/kg/day, increase by 1 mg/kg weekly up to 6–9 mg/kg/day
• Timing: BID
• Side Effects: Cognitive slowing, weight loss, kidney stones, metabolic acidosis verywellhealth.com.

6. Clobazam (Onfi)
• Class: Benzodiazepine
• Dosage: 0.25–0.5 mg/kg/day in divided doses
• Timing: BID
• Side Effects: Sedation, behavior changes, tolerance verywellhealth.com.

7. Clonazepam (Klonopin)
• Class: Benzodiazepine
• Dosage: 0.01–0.03 mg/kg/day in divided doses
• Timing: BID or TID
• Side Effects: Sedation, ataxia, tolerance verywellhealth.com.

8. Oxcarbazepine (Trileptal)
• Class: Sodium-channel blocker
• Dosage: Start 8 mg/kg/day, titrate to 30 mg/kg/day
• Timing: BID
• Side Effects: Hyponatremia, somnolence, dizziness verywellhealth.com.

9. Phenobarbital
• Class: Barbiturate
• Dosage: 3–5 mg/kg/day once daily
• Timing: Single dose at bedtime
• Side Effects: Sedation, cognitive impairment, dependence verywellhealth.com.

10. Ethosuximide (Zarontin)
• Class: T‐type calcium channel blocker
• Dosage: 20 mg/kg/day in two doses, up to 40 mg/kg/day
• Timing: BID
• Side Effects: GI upset, lethargy, headache verywellhealth.com.

11. Gabapentin (Neurontin)
• Class: GABA analogue
• Dosage: 10 mg/kg TID, titrate to 40 mg/kg/day
• Timing: TID
• Side Effects: Dizziness, somnolence, weight gain verywellhealth.com.

12. Pregabalin (Lyrica)
• Class: GABA analogue
• Dosage: 2–3 mg/kg/day in two divided doses
• Timing: BID
• Side Effects: Edema, dizziness, weight gain verywellhealth.com.

13. Diazepam Rectal Gel (Diastat)
• Class: Benzodiazepine
• Dosage: 0.2–0.5 mg/kg as needed for acute seizure clusters
• Timing: PRN
• Side Effects: Drowsiness, respiratory depression verywellhealth.com.

14. Nasal Midazolam (Nayzilam)
• Class: Benzodiazepine
• Dosage: 0.2 mg/kg (max 5 mg) per episode
• Timing: PRN
• Side Effects: Sedation, nasal irritation verywellhealth.com.

15. Baclofen
• Class: GABA_B agonist (for spasticity)
• Dosage: 0.3–0.5 mg/kg/day in divided doses
• Timing: TID
• Side Effects: Sedation, weakness, hypotonia dcf.psychiatry.ufl.edu.

16. Tizanidine (Zanaflex)
• Class: α_2‐adrenergic agonist (for spasticity)
• Dosage: 0.5–2 mg TID
• Timing: TID
• Side Effects: Hypotension, dry mouth, sedation dcf.psychiatry.ufl.edu.

17. Omeprazole (Prilosec)
• Class: Proton-pump inhibitor (for reflux)
• Dosage: 0.7–1 mg/kg once daily
• Timing: Morning before meals
• Side Effects: Headache, abdominal pain, diarrhea chop.edu.

18. Polyethylene Glycol (Miralax)
• Class: Osmotic laxative (for constipation)
• Dosage: 0.4–0.8 g/kg/day
• Timing: Once daily
• Side Effects: Bloating, cramping ncbi.nlm.nih.gov.

19. Domperidone
• Class: Dopamine antagonist (prokinetic)
• Dosage: 0.25–0.5 mg/kg TID
• Timing: TID before meals
• Side Effects: Dry mouth, headache, QT prolongation chop.edu.

20. Risperidone (Risperdal)
• Class: Atypical antipsychotic (for behavioral issues)
• Dosage: 0.25 mg once daily, titrate by 0.25 mg every week to 1–2 mg/day
• Timing: Once daily in the evening
• Side Effects: Weight gain, sedation, metabolic changes dcf.psychiatry.ufl.edu.


Dietary Molecular Supplements

1. Omega-3 Fatty Acids
Dosage: 1 000 mg DHA+EPA daily.
Function: Supports neuronal membrane fluidity and anti-inflammatory pathways.
Mechanism: Modulates eicosanoid synthesis and enhances synaptic plasticity pubmed.ncbi.nlm.nih.gov.

2. Vitamin D3
Dosage: 400–1 000 IU daily.
Function: Neurodevelopmental support, immune modulation.
Mechanism: Regulates neurotrophic factors and calcium homeostasis en.wikipedia.org.

3. Vitamin B12
Dosage: 500 µg daily.
Function: Methylation reactions, myelin synthesis.
Mechanism: Cofactor in methionine cycle and neurotransmitter production en.wikipedia.org.

4. Folic Acid
Dosage: 400–800 µg daily.
Function: Neurogenesis support.
Mechanism: DNA synthesis, methylation of neural genes en.wikipedia.org.

5. Choline
Dosage: 250 mg daily.
Function: Precursor for acetylcholine and phosphatidylcholine.
Mechanism: Enhances cholinergic transmission and membrane integrity en.wikipedia.org.

6. Magnesium
Dosage: 6 mg/kg/day.
Function: NMDA receptor modulation and muscle tone regulation.
Mechanism: Acts as calcium channel antagonist in neurons en.wikipedia.org.

7. Zinc
Dosage: 0.5 mg/kg/day.
Function: Synaptic plasticity and immune support.
Mechanism: Cofactor for enzymes in neurotransmitter synthesis en.wikipedia.org.

8. Probiotics
Dosage: 1 × 10^9 CFU daily.
Function: Gut-brain axis modulation.
Mechanism: Influences neurotransmitter production via microbiota metabolites en.wikipedia.org.

9. Creatine
Dosage: 200 mg/kg/day.
Function: Cellular energy support.
Mechanism: Increases phosphocreatine stores for ATP regeneration en.wikipedia.org.

10. Coenzyme Q10
Dosage: 100 mg daily.
Function: Mitochondrial antioxidant.
Mechanism: Electron transport chain support and free radical scavenging en.wikipedia.org.


Specialized Regenerative & Supportive Agents

1. Alendronate (Fosamax)
• Class: Bisphosphonate
• Dosage: 70 mg once weekly
• Function: Inhibits osteoclasts to improve bone density.
• Mechanism: Binds hydroxyapatite and blocks farnesyl pyrophosphate synthase in osteoclasts dcf.psychiatry.ufl.edu.

2. Zoledronic Acid (Reclast)
• Class: Bisphosphonate
• Dosage: 0.05 mg/kg IV once annually
• Function: Enhances skeletal strength.
• Mechanism: Potent osteoclast inhibition via mevalonate pathway blockade dcf.psychiatry.ufl.edu.

3. Denosumab (Prolia)
• Class: RANKL inhibitor
• Dosage: 60 mg subcutaneously every 6 months
• Function: Reduces bone resorption.
• Mechanism: Monoclonal antibody binds RANKL, preventing osteoclast maturation dcf.psychiatry.ufl.edu.

4. Hyaluronic Acid (Viscosupplementation)
• Class: Glycosaminoglycan injection
• Dosage: 20 mg intra-articular weekly for 3 weeks
• Function: Lubricates joints to reduce pain.
• Mechanism: Restores synovial fluid viscosity and protects cartilage dcf.psychiatry.ufl.edu.

5. Platelet-Rich Plasma (PRP)
• Class: Autologous growth factors
• Dosage: 2–3 mL intra-tissue injection monthly for 3 months
• Function: Promotes tissue regeneration.
• Mechanism: Concentrated platelet cytokines (PDGF, TGF-β) enhance healing dcf.psychiatry.ufl.edu.

6. Autologous Mesenchymal Stem Cells
• Class: Regenerative cell therapy
• Dosage: 1 × 10^6 cells/kg IV or intrathecal
• Function: Neuroprotection and repair.
• Mechanism: Paracrine secretion of neurotrophic factors and immunomodulation dcf.psychiatry.ufl.edu.

7. Umbilical Cord-Derived MSCs
• Class: Regenerative cell therapy
• Dosage: 2 × 10^6 cells/kg IV infusion
• Function: Supports neuronal growth.
• Mechanism: Anti-inflammatory cytokine release and tissue remodeling dcf.psychiatry.ufl.edu.

8. Recombinant Human Growth Hormone (rhGH)
• Class: Growth factor
• Dosage: 0.035 mg/kg/day subcutaneously
• Function: Improves lean mass and bone density.
• Mechanism: Stimulates IGF-1 production, promoting anabolism dcf.psychiatry.ufl.edu.

9. Bone Morphogenetic Protein-2 (BMP-2)
• Class: Osteoinductive growth factor
• Dosage: 1.5 mg/cm^3 in scaffold application
• Function: Enhances bone formation.
• Mechanism: BMP receptor activation drives osteoblast differentiation dcf.psychiatry.ufl.edu.

10. Viscous Corticosteroid Joint Injection
• Class: Anti-inflammatory agent
• Dosage: 1–2 mg triamcinolone intra-articular
• Function: Reduces joint inflammation and pain.
• Mechanism: Inhibits phospholipase A2 and cytokine production dcf.psychiatry.ufl.edu.


Surgical Interventions

  1. Gastrostomy Tube Placement
    Procedure: Surgical insertion of feeding tube into stomach.
    Benefits: Ensures adequate nutrition in severe feeding difficulties en.wikipedia.org.

  2. Nissen Fundoplication
    Procedure: Wrapping gastric fundus around lower esophageal sphincter.
    Benefits: Controls reflux, reduces aspiration risk en.wikipedia.org.

  3. Gingivectomy
    Procedure: Surgical removal of enlarged gingival tissue.
    Benefits: Improves oral hygiene and prevents periodontal disease en.wikipedia.org.

  4. Orthopedic Contracture Release
    Procedure: Lengthening of tendons/muscles (e.g., Achilles).
    Benefits: Enhances joint range and reduces spastic gait ncbi.nlm.nih.gov.

  5. Palatoplasty (Cleft Palate Repair)
    Procedure: Surgical closure of palatal cleft.
    Benefits: Improves feeding, speech, and midface growth en.wikipedia.org.

  6. Strabismus Surgery
    Procedure: Extraocular muscle resection or recession.
    Benefits: Corrects eye alignment, reduces amblyopia risk en.wikipedia.org.

  7. Hip Dysplasia Open Reduction
    Procedure: Surgical realignment of hip joint.
    Benefits: Prevents dislocation and preserves function ncbi.nlm.nih.gov.

  8. Tracheopexy (Tracheomalacia Repair)
    Procedure: Suspension of floppy tracheal walls.
    Benefits: Improves airway stability and reduces respiratory events ncbi.nlm.nih.gov.

  9. Vagus Nerve Stimulator (VNS) Implantation
    Procedure: Electrodes on left vagus nerve connected to pulse generator.
    Benefits: Reduces refractory seizure frequency by neuromodulation en.wikipedia.org.

  10. Corpus Callosotomy
    Procedure: Partial or complete severing of corpus callosum.
    Benefits: Reduces drop attacks and generalized seizures en.wikipedia.org.


Preventive Strategies

  1. Prenatal Genetic Counseling
    Discuss inheritance risks and reproductive options en.wikipedia.org.

  2. Preimplantation Genetic Diagnosis (PGD)
    Screen embryos for WDR26 variants en.wikipedia.org.

  3. Early Newborn Screening
    Monitor developmental milestones from birth ncbi.nlm.nih.gov.

  4. Avoidance of Neurotoxins During Pregnancy
    Minimize alcohol, certain medications, infections en.wikipedia.org.

  5. Folic Acid Supplementation
    Reduces neural tube defect risks en.wikipedia.org.

  6. Optimized Maternal Nutrition
    Ensure adequate vitamins D, B12, iodine en.wikipedia.org.

  7. Early Intervention Enrollment
    Initiate PT, OT, speech therapies by 3 months if delay noted en.wikipedia.org.

  8. Regular Developmental Surveillance
    Pediatric checkups with standardized screening tools ncbi.nlm.nih.gov.

  9. Seizure First-Aid Training
    Educate caregivers on safe positioning and emergency protocols en.wikipedia.org.

  10. Immunization Adherence
    Prevent CNS infections (e.g., meningitis) that can worsen outcomes ncbi.nlm.nih.gov.


When to See a Doctor

Caregivers should seek medical evaluation promptly if any of the following occur:

  • Onset of new or worsening seizures en.wikipedia.org

  • Regression or plateau of developmental milestones ncbi.nlm.nih.gov

  • Persistent feeding difficulties or failure to thrive en.wikipedia.org

  • Increased dystonia, contractures, or loss of motor skills

  • Signs of respiratory distress (e.g., due to tracheomalacia)


What to Do and What to Avoid

What to Do

  1. Establish routine early intervention therapies en.wikipedia.org.

  2. Maintain a seizure diary en.wikipedia.org.

  3. Use adaptive feeding strategies (thickened feeds, pacing)

  4. Ensure safety-proofed environment (falls, aspiration)

  5. Collaborate with multidisciplinary team (PT, OT, SLP)

What to Avoid

  1. Abrupt medication changes without supervision en.wikipedia.org.

  2. Overstimulating environments if they trigger seizures

  3. High-impact sports without adaptive equipment

  4. Unsupervised water activities (aspiration risk)

  5. Ignoring signs of respiratory compromise or infection


Frequently Asked Questions

  1. What causes Skraban–Deardorff syndrome?
    Pathogenic variants in the WDR26 gene causing haploinsufficiency and disrupted protein degradation pathways en.wikipedia.org.

  2. How is it diagnosed?
    Genetic testing (chromosomal microarray or exome sequencing) confirming a pathogenic WDR26 variant in a child with characteristic features en.wikipedia.org.

  3. Can it be inherited?
    Most cases are de novo, but if inherited, it follows autosomal dominant transmission with 50% recurrence risk en.wikipedia.org.

  4. Is there a cure?
    No cure exists; management is supportive and focuses on symptoms and developmental support en.wikipedia.org.

  5. What specialists are involved in care?
    Geneticists, neurologists, developmental pediatricians, physical, occupational, speech therapists en.wikipedia.org.

  6. Why do children have a happy demeanor?
    Characteristic sociable “happy” disposition is part of the neurobehavioral phenotype en.wikipedia.org.

  7. What seizure types occur?
    Generalized tonic–clonic, absence, rolandic, and febrile seizures en.wikipedia.org.

  8. How common is malignancy risk?
    No known increased cancer risk associated with WDR26 variants en.wikipedia.org.

  9. Are feeding tubes often needed?
    Temporary gastrostomy may be required if oral feeding fails and failure to thrive ensues en.wikipedia.org.

  10. Can speech improve?
    Many children make gains with speech therapy; some remain nonverbal en.wikipedia.org.

  11. What supports educationally?
    Individualized Education Programs (IEPs) tailored to cognitive profile en.wikipedia.org.

  12. Do facial features change over time?
    Facial dysmorphisms become less pronounced but often remain distinct en.wikipedia.org.

  13. Is genetic counseling recommended?
    Yes, for family planning and understanding recurrence risk en.wikipedia.org.

  14. How often should developmental surveillance occur?
    At least every 6 months, more frequently if concerns arise ncbi.nlm.nih.gov.

  15. Are there support organizations?
    Skraban–Deardorff Syndrome Foundation, NORD, and CHOP Clinic provide resources and community support skdeas.org.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 08, 2025.

RxHarun
Logo